NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 764037 | BP-1-102 | 0.0244718705444135 | 0.42833211 |
NSC 130862 | Null | 0.0244718705444139 | 0.39104704 |
NSC 154829 | 7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamidoxime, 4-(hydroxyamino)-7-.beta.-D-ribofuranosyl-, monohydrochloride | 0.0244718705444139 | 0.26539771 |
NSC 15812 | Null | 0.0244718705444139 | 0.24344599 |
NSC 254681 | 5(8H)-Naphthacenone, 8-acetyl-10-[(3-amino-2,3,6-trideoxy- .alpha.-L-lyxo-hexopyranosyl)oxy]-7,9,10,12-tetrahydro-6,8,~ 11-trihydroxy-12-imino-1-methoxy-, monohydrochloride, (8S-cis)- (9CI) | 0.0244718705444139 | 0.27510011 |
NSC 315844 | 2(1H)-Pyrimidinone, 1-(2,5-dihydro-5-oxo-2-furanyl)-5-fluoro-4-methoxy- | 0.0244718705444139 | 0.3858077 |
NSC 58239 | A 80021F34 | 0.0244718705444139 | 0.1950425 |
NSC 624659 | ANTINEOPLASTIC-624659 | 0.0244718705444139 | 0.58807901 |
NSC 628141 | Null | 0.0244718705444139 | 0.18006596 |
NSC 629736 | Null | 0.0244718705444139 | 0.15701077 |